Phenotypic and Molecular Features of Somatically Derived “Yolk Sac Tumors”: Similarities and Differences With Counterparts of Germ Cell Origin
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2025.100807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von João Lobo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal;…. Hauptthemen laut MEDLINE: Endodermal Sinus Tumor, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Cancer Institute, Mayo Clinic Arizona, Francisco Gentil Portuguese Institute for Oncology of Porto.
Abstract (Originalsprache)
A subset of somatic carcinomas shows morphologic and immunophenotypic similarities to yolk sac tumor (YST) of germ cell origin, including fetal adenocarcinomas of the lung and somatic carcinomas with "YST"/enteroblastic differentiation. At least some of these tumors may result from reprogramming somatic cancer cells, leading to the acquisition of a "pluripotent" phenotype. Although these somatic tumors express markers such as SALL4, glypican 3, and alpha-fetoprotein, which are positive in germ cell-derived YST, it is currently uncertain to what degree their molecular features overlap with those of germ cell tumors (GCTs). We assessed i(12p) (fluorescence in situ hybridization) and levels of micro-RNA-371-373 (real-time PCR), hallmarks of germ cell neoplasia in situ (GCNIS)-derived GCTs, in a cohort of 11 somatically derived neoplasms with YST/enteroblastic phenotype (designated as "YST-like" tumors hereafter). In addition, we used immunohistochemistry to assess expression of FOXA2, a critical regulator of induction and maintenance of YST phenotype in GCTs. All YST-like tumors showed expression of FOXA2 and were negative for i(12p). Expression of miR-371a-3p (the most specific member of the miR-371-373 cluster) was detectable in 6 of 10 (60%) of YST-like tumors. Four samples showed levels in the gray zone of detection (ie, expression of uncertain clinical significance), and 2 samples (separate tumors from a single patient) showed positive levels similar to those found in nonteratoma GCNIS-derived GCTs. The remaining members of the micro-RNA cluster (miRs 372 and 373) followed the same patterns. Our results show that the overlap of somatically derived YST-like tumors and YSTs of germ cell origin goes beyond morphology, including expression of one of the master regulators of the YST phenotype and, in some cases, miR-371a-3p. However, these neoplasms lack a hallmark finding of GCNIS-derived GCTs (i[12p]) and show significant biologic and clinical differences with GCTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC…
- Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal; Doctoral Progr…
- Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal.
- Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (P.CCC), Porto, Portugal; Department of…
- Pathology Unit, DIAP-Dipartimento Interaziendale di anatomia patologica di Bologna, Maggiore Hospital-Azienda Unità Sanitaria Locale Bologna, Bologna, Italy.
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; Solid Tumor Molecular Pathology Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero-Universitar…
Förderung
- National Cancer Institute
- Mayo Clinic Arizona
- Francisco Gentil Portuguese Institute for Oncology of Porto
- Foundation for Science and Technology
Zitieren
APA
Lobo, J., Tavares, N. T., Fernandes-Pontes, F., Fonseca, D., Jerónimo, C., Henrique, R., Ricci, C., de Leo, A., Collins, K., Idrees, M. T., Ulbright, T. M., Gupta, S., & Acosta, A. M. (2025). Phenotypic and Molecular Features of Somatically Derived “Yolk Sac Tumors”: Similarities and Differences With Counterparts of Germ Cell Origin. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100807
Vancouver
Lobo J, Tavares NT, Fernandes-Pontes F, Fonseca D, Jerónimo C, Henrique R, et al. Phenotypic and Molecular Features of Somatically Derived “Yolk Sac Tumors”: Similarities and Differences With Counterparts of Germ Cell Origin. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100807
BibTeX
@article{Lobo2025,
author = {Lobo, João and Tavares, Nuno Tiago and Fernandes-Pontes, Fernanda and Fonseca, Diana and Jerónimo, Carmen and Henrique, Rui and Ricci, Costantino and de Leo, Antonio and Collins, Katrina and Idrees, Muhammad T and Ulbright, Thomas M and Gupta, Sounak and Acosta, Andres M},
title = {Phenotypic and Molecular Features of Somatically Derived “Yolk Sac Tumors”: Similarities and Differences With Counterparts of Germ Cell Origin},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2025.100807}
}
EUVIMED